What We're Reading: Page 218
Industry reads hand-picked by our editors
Mar 12, 2020
-
The New York Times
A ‘New Normal’ for Hospitals on the Front Lines Fighting Coronavirus
-
San Francisco Business Times
Two people on Genentech campus test positive for COVID-19
-
STAT
Coronavirus vaccine clinical trial starting without usual animal data
Mar 11, 2020
-
The Boston Globe
How the Biogen leadership conference in Boston spread the coronavirus
-
The New York Times
How Coronavirus Hijacks Your Cells
-
The Wall Street Journal
Regeneron, Sanofi to Test Arthritis Drug as Coronavirus Treatment
-
POLITICO
U.S. coronavirus testing threatened by shortage of critical lab materials
Mar 10, 2020
-
The Wall Street Journal
How Biogen’s Strategy Meeting Spread Coronavirus in Massachusetts and Beyond
-
Reuters
Syneos Health exploring a sale: sources
-
Bloomberg
Texas Baboon Troop Enlisted in Humankind's War on Coronavirus
-
The New York Times
The ‘London Patient,’ Cured of H.I.V., Reveals His Identity
Mar 09, 2020
Mar 06, 2020
-
POLITICO
How the drug industry got its way on the coronavirus
-
MM&M
Bristol Myers Squibb unveils new branding, will phase out Celgene brand
-
Bloomberg
The Search for New Drugs for Coronavirus Faces Long Odds
-
The Wall Street Journal
Sanofi, Fighting Back in Insulin Price Debate, Says Its Net Prices Fell 11%
Mar 05, 2020
-
MIT Technology Review
Gene sleuths are tracking the coronavirus outbreak as it happens
-
Axios
Big Pharma is on a stock buyback spree
-
The Wall Street Journal
Recruitment Begins for First Test of Experimental Coronavirus Vaccine
-
STAT
Vertex battles Canada over access to cystic fibrosis treatments
Mar 04, 2020
-
The Washington Post
Why Facebook is filled with pharmaceutical ads
-
The New York Times
As Coronavirus Disrupts Factories, India Curbs Exports of Key Drugs
-
STAT
Passage Bio went public during the stock market’s worst week since 2008
-
Reuters
China approves use of Roche drug in battle against coronavirus complications
Previous
